Hylek EM - Search Results

1

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz JD, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Wallentin L, et al. Among authors: hylek em. Circulation. 2013 Jun 4;127(22):2166-76. doi: 10.1161/CIRCULATIONAHA.112.142158. Epub 2013 May 2. Circulation. 2013. PMID: 23640971 Clinical Trial.

2

Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, Selby JV, Singer DE. Go AS, et al. Among authors: hylek em. Circulation. 2000 Jul 4;102(1):11-3. doi: 10.1161/01.cir.102.1.11. Circulation. 2000. PMID: 10880408

3

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. Ansell J, et al. Chest. 2004 Sep;126(3 Suppl):204S-233S. doi: 10.1378/chest.126.3_suppl.204S. Chest. 2004. PMID: 15383473

4

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Fang MC, et al. Among authors: hylek em. Circulation. 2005 Sep 20;112(12):1687-91. doi: 10.1161/CIRCULATIONAHA.105.553438. Epub 2005 Sep 12. Circulation. 2005. PMID: 16157766 Free PMC article.

5

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.

Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Hylek EM, et al. Circulation. 2007 May 29;115(21):2689-96. doi: 10.1161/CIRCULATIONAHA.106.653048. Epub 2007 May 21. Circulation. 2007. PMID: 17515465

6

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Ansell J, et al. Chest. 2008 Jun;133(6 Suppl):160S-198S. doi: 10.1378/chest.08-0670. Chest. 2008. PMID: 18574265

7

Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician.

Lopes RD, Piccini JP, Hylek EM, Granger CB, Alexander JH. Lopes RD, et al. Among authors: hylek em. J Thromb Thrombolysis. 2008 Dec;26(3):167-74. doi: 10.1007/s11239-008-0272-4. Epub 2008 Sep 21. J Thromb Thrombolysis. 2008. PMID: 18807225 Review.

8

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.

Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, Gersh BJ, Granger CB, Hanna M, Horowitz J, Hylek EM, McMurray JJ, Verheugt FW, Wallentin L; ARISTOTLE Investigators. Lopes RD, et al. Among authors: hylek em. Am Heart J. 2010 Mar;159(3):331-9. doi: 10.1016/j.ahj.2009.07.035. Am Heart J. 2010. PMID: 20211292 Clinical Trial.

9

New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.

Garcia DA, Lopes RD, Hylek EM. Garcia DA, et al. Among authors: hylek em. Thromb Haemost. 2010 Dec;104(6):1099-105. doi: 10.1160/TH10-07-0491. Epub 2010 Sep 30. Thromb Haemost. 2010. PMID: 20886196 Review.

10

Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification.

Cabral KP, Ansell J, Hylek EM. Cabral KP, et al. Among authors: hylek em. J Thromb Haemost. 2011 Mar;9(3):441-9. doi: 10.1111/j.1538-7836.2010.04179.x. J Thromb Haemost. 2011. PMID: 21176102 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page